Listing
Nephrocare IPO pops on debut, dialysis major lists at 7% premium
Mumbai/IBNS: Shares of dialysis service provider Nephrocare Health Services made a strong market debut on Wednesday, listing at a premium of about 7 per cent on the bourses, media reports said.
The stock debuted at ₹491.70 on the BSE, a premium of 6.8 per cent over the issue price, while it listed at ₹490 on the NSE, reflecting a 6.52 per cent premium, CNBC-TV18 reported.
Nephrocare’s ₹871.05-crore initial public offering (IPO), which was open for subscription from December 10 to 12, was subscribed 13.96 times at the close of bidding.
The issue attracted bids worth nearly ₹8,600 crore from more than 4.54 lakh investors.
The IPO comprised a fresh issue of shares along with an offer for sale (OFS) by existing shareholders. The price band for the issue was fixed at ₹438–₹460 per share.
The strong listing performance reflects investor confidence in Nephrocare Health Services, a leading organised provider of dialysis and nephrology care in India and parts of Asia.
Market participants attribute the positive debut to the company’s expanding network and growth prospects.
Nephrocare Health Services Ltd., which operates the NephroPlus dialysis network, made its stock market debut on December 17, 2025.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
